Stay updated on Immunogenic Nivolumab + Ipilimumab in Prostate Cancer Clinical Trial

Sign up to get notified when there's something new on the Immunogenic Nivolumab + Ipilimumab in Prostate Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Immunogenic Nivolumab + Ipilimumab in Prostate Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Removed the “Prostate cancer” related topics links, including the MedlinePlus Genetics section.
    Difference
    0.2%
    Check dated 2026-04-23T14:13:26.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Added Prostate cancer and MedlinePlus Genetics as related topics and updated the revision from v3.5.0 to v3.5.2.
    Difference
    0.2%
    Check dated 2026-04-16T10:18:49.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The 'Prostate cancer' topic and 'MedlinePlus Genetics' related topics were removed from the page, reducing contextual keywords and navigation cues for users.
    Difference
    0.2%
    Check dated 2026-04-09T08:05:49.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    Added Prostate cancer as a related topic and a MedlinePlus Genetics link.
    Difference
    0.2%
    Check dated 2026-04-02T00:39:09.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-18T15:45:19.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Added page revision note: Revision: v3.4.3. Removed Prostate cancer-related topics including MedlinePlus Genetics (Revision: v3.4.2).
    Difference
    0.2%
    Check dated 2026-03-11T14:35:27.000Z thumbnail image

Stay in the know with updates to Immunogenic Nivolumab + Ipilimumab in Prostate Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Immunogenic Nivolumab + Ipilimumab in Prostate Cancer Clinical Trial page.